Browsing by Subject
Ara mostrant els elements 21-40 d 115
-
Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial Results
(American Society of Clinical Oncology, 2023-10-20) -
Biomarker Analysis of the Phase III NALA Study of Neratinib + Capecitabine versus Lapatinib + Capecitabine in Patients with Previously Treated Metastatic Breast Cancer
(American Association for Cancer Research, 2021-11-01) -
Current Perspectives and Novel Strategies of NRAS-Mutant Melanoma
(Dove Medical Press, 2021-06-09) -
Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial
(Nature Portfolio, 2023-05) -
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial
(Nature Portfolio, 2024-01) -
Efficacy and Safety of the MDM2–p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced Biliary Tract Cancer: A Case Series
(Dove Medical Press, 2024-03-29) -
Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer A Phase 3 Randomized Clinical Trial
(American Medical Association, 2021-04) -
Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E–Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study
(American Society of Clinical Oncology, 2021-02-01)